Quantitative Investment Management LLC purchased a new stake in Colgate-Palmolive (NYSE:CL) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 92,600 shares of the company’s stock, valued at approximately $6,986,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Point72 Asset Management L.P. purchased a new position in Colgate-Palmolive in the third quarter valued at about $1,814,000. The Manufacturers Life Insurance Company boosted its holdings in Colgate-Palmolive by 10.3% in the second quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock valued at $83,914,000 after purchasing an additional 105,878 shares during the last quarter. Pensionfund DSM Netherlands purchased a new position in Colgate-Palmolive in the third quarter valued at about $4,225,000. Pictet & Cie Europe SA boosted its holdings in Colgate-Palmolive by 5.5% in the third quarter. Pictet & Cie Europe SA now owns 123,000 shares of the company’s stock valued at $8,961,000 after purchasing an additional 6,400 shares during the last quarter. Finally, Roosevelt Investment Group Inc. acquired a new stake in Colgate-Palmolive during the second quarter valued at approximately $1,044,000. 73.87% of the stock is owned by hedge funds and other institutional investors.
In related news, Vice Chairman Franck J. Moison sold 142,979 shares of the stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $70.09, for a total value of $10,021,398.11. Following the completion of the transaction, the insider now directly owns 224,027 shares of the company’s stock, valued at approximately $15,702,052.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Daniel B. Marsili sold 5,692 shares of the stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $70.19, for a total value of $399,521.48. Following the completion of the transaction, the insider now directly owns 41,677 shares of the company’s stock, valued at $2,925,308.63. The disclosure for this sale can be found here. Insiders have sold a total of 463,082 shares of company stock worth $32,983,130 over the last quarter. Insiders own 1.02% of the company’s stock.
Shares of Colgate-Palmolive (NYSE:CL) opened at $71.24 on Monday. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02. The firm has a market capitalization of $62,358.27, a P/E ratio of 24.82, a PEG ratio of 2.64 and a beta of 0.79. Colgate-Palmolive has a 1 year low of $68.19 and a 1 year high of $77.91.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.75. The business had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.75 EPS. research analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.36%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio is presently 70.18%.
COPYRIGHT VIOLATION NOTICE: “Quantitative Investment Management LLC Takes $6.99 Million Position in Colgate-Palmolive (CL)” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/03/12/quantitative-investment-management-llc-takes-6-99-million-position-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.